Cleveland Clinic Names New Chair of Pathology and Laboratory Medicine Institute

Brian Rubin, M.D., Ph.D., brings 17 years of experience to the role

Brian Rubin, M.D., Ph.D., chair of Cleveland Clinic’s Robert J. Tomsich Pathology & Laboratory Medicine Institute

Following an extensive national search, Cleveland Clinic has appointed Brian Rubin, M.D., Ph.D., as chair of the Robert J. Tomsich Pathology & Laboratory Medicine Institute (RT-PLMI).

In this role, Dr. Rubin will oversee 1,500 caregivers and 100 pathologists who process more than 19 million tests annually, touching virtually every Cleveland Clinic patient and thousands of others around the world.

Dr. Rubin joined Cleveland Clinic in 2006. Prior to this appointment, he served as vice-chair of research and director of soft tissue pathology at RT-PLMI. He also is professor of Pathology at Cleveland Clinic Lerner College of Medicine.

Dr. Rubin’s career has been dedicated to better understanding the diagnosis and classification of soft tissue neoplasms, especially sarcomas, where he is a prominent national and international figure. He is widely regarded as a thought leader in the field and is a founding member of the International Society of Bone and Soft Tissue Pathology. His laboratory focuses on understanding the pathogenesis of sarcomas with the major aim of developing targeted therapies.

“Brian is an exceptional leader who is committed to quality, mentoring and program development,” said Cleveland Clinic Chief of Staff Herbert Wiedemann, M.D. “He brings a wealth of knowledge, expertise and understanding to this position.”

Dr. Rubin also will be responsible for overseeing the institute’s academic and research mission. RT-PLMI is an active teaching center with 28 residents as well as fellowships in nine specialty areas.

“It is a privilege to be given the opportunity to lead our extraordinary group of caregivers,” Dr. Rubin said. “I look forward to working together to continue to improve quality, safety and the patient experience.”

Dr. Rubin earned his Ph.D. in molecular biology and M.D. from Cornell University Medical College. He completed residency training in anatomic pathology and a fellowship in soft tissue/bone pathology and cancer genetics at Brigham and Women’s Hospital.

Dr. Rubin succeeds Robert Wyllie, M.D., Chief Medical Operations Officer, who served as interim chair of RT-PLMI since September 2016.

 

About Cleveland Clinic

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Among Cleveland Clinic’s 52,000 employees are more than 3,600 full-time salaried physicians and researchers and 14,000 nurses, representing 140 medical specialties and subspecialties. Cleveland Clinic’s health system includes a 165-acre main campus near downtown Cleveland, 10 regional hospitals, more than 150 northern Ohio outpatient locations – including 18 full-service family health centers and three health and wellness centers – and locations in Weston, Fla.; Las Vegas, Nev.; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2017, there were 7.6 million outpatient visits, 229,000 hospital admissions and 207,000 surgical cases throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/ClevelandClinic. News and resources available at newsroom.clevelandclinic.org.